SETH LEDERMAN - 15 May 2025 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Chief Executive Officer, Director
Signature
/s/ Seth Lederman
Issuer symbol
TNXP
Transactions as of
15 May 2025
Transactions value $
$86,200
Form type
4
Filing time
15 May 2025, 17:08:40 UTC
Previous filing
27 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LEDERMAN SETH Chief Executive Officer, Director C/O TONIX PHARMACEUTICALS HOLDING CORP, 26 MAIN ST., SUITE 101, CHATHAM /s/ Seth Lederman 15 May 2025 0001563420

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, $0.001 par value Purchase $86,200 +4,000 +80,000% $21.55 4,005 15 May 2025 Direct
holding TNXP Common Stock, $0.001 par value 1 15 May 2025 By IRA Account
holding TNXP Common Stock, $0.001 par value 1 15 May 2025 Lederman & Co. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person may be deemed to be a control person of this entity.